Partex NV is ​the first digital ​pharma platform that is set to be the largest AI-powered Drug Assets Manager. 

With the power of AI at its core, we at Partex NV Group deliver faster, lower-cost healthcare innovations, validated by wet-lab and real-world evidence. Our pioneering digital platform enables smarter decision-making throughout the entire value chain.

What sets us ​apart:
​- Within the Partex ​ecosystem, patients ​​keep ownership of ​their data and they are rewarded for ​participating in research projects
- ​Our ​AI/ML algorithms enable key ​industry players to develop life-saving drugs while also developing our own drug assets
- A ​strong history of success and ​performance: from humble software beginnings to a ​fully-fledged platform with over ​250 employees in 3 continents

Our vision is to transform the ​Life science Industry​ by curing incurable diseases and increasing humanity's longevity. We dare to care!

​We have a global presence that extends from ​APAC to ​the Americas, with offices currently in India, Germany, Switzerland and ​USA.

CEO & Co-Founder: Dr. Gunjan Bhardwaj
Chairman & Co-Founder: Francisco Fernandez

Companies belonging to Partex group: 
www.innoplexus.com
www.cureteq.com
www.perpetualblock.io
www.amrit.ai
www.assay.works

Health Data

Pharmaceutical

AI/ML

Life Sciences

Partex

Gunjan Bhardwaj

Karen P. Zimmer

Dr. Michael Schulz

Bhupesh Khimani

Tamara K.

Sanjee Tawde

Sven Krause

Volker Menschik

Partex

Org chart

Teams

Similar companies